EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancy

Christopher W Rowe iD, Patrick Rosee, Angeline Sathiakumar, Soundarya Ramesh, Vivian Qiao, Jason Huynh, Georgia Dennien, Natasha Weaver, Katie Wynne

Diabetic Medicine · 2024

DOI: 10.1111/dme.15262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diabetic Medicine, 2024. Verfasst von Christopher W Rowe und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Diabetes, John Hunter Hospital, Newcastle, New South Wales, Australia. Hauptthemen laut MEDLINE: Diabetes, Gestational, Diabetes Mellitus, Type 2, Hyperglycemia, Pre-Eclampsia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Bespoke glycaemic control strategies following antenatal corticosteroids for women with diabetes in pregnancy (DIP) may mitigate hyperglycaemia. This study aims to identify predictive factors for the glycaemic response to betamethasone in a large cohort of women with DIP.

Methods

Evaluation of a prospective cohort study of 347 consecutive DIP pregnancies receiving two doses of 11.4 mg betamethasone 24 h apart between 2017 and 2021 and treated with the Pregnancy‐IVI intravenous insulin protocol. Regression modelling identified factors associated with maternal glycaemic time‐in‐range (TIR) and maternal insulin requirements following betamethasone. Factors associated with neonatal hypoglycaemia (glucose

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalDiabetes Mellitus, Type 2HyperglycemiaPre-EclampsiaHypoglycemiaPregnancy in DiabeticsFetal DiseasesInfant, NewbornPregnancyFemaleHumansAdultInfantBetamethasoneProspective StudiesParturitionInsulinGlucose

Stichwörter der Autor:innen

gestational diabetesinsulin deliveryinsulin resistanceneonatal hypoglycaemiasteroid hormone

Substanzen

BetamethasoneInsulinGlucose

Autor:innen und Institutionen

  • Department of Endocrinology and Diabetes, John Hunter Hospital, Newcastle, New South Wales, Australia.
  • School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.
  • Hunter Medical Research Institute, New Lambton Heights, New South Wales, Australia.

ORCID-Profile: Christopher W Rowe

Zitieren

APA

Rowe, C. W., Rosee, P., Sathiakumar, A., Ramesh, S., Qiao, V., Huynh, J., Dennien, G., Weaver, N., & Wynne, K. (2024). Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancy. Diabetic Medicine. https://doi.org/10.1111/dme.15262

Vancouver

Rowe CW, Rosee P, Sathiakumar A, Ramesh S, Qiao V, Huynh J, et al. Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancy. Diabetic Medicine. 2024. doi:10.1111/dme.15262

BibTeX
@article{Rowe2024,
  author = {Rowe, Christopher W and Rosee, Patrick and Sathiakumar, Angeline and Ramesh, Soundarya and Qiao, Vivian and Huynh, Jason and Dennien, Georgia and Weaver, Natasha and Wynne, Katie},
  title = {Factors associated with maternal hyperglycaemia and neonatal hypoglycaemia after antenatal betamethasone administration in women with diabetes in pregnancy},
  journal = {Diabetic Medicine},
  year = {2024},
  doi = {10.1111/dme.15262}
}
Kostenlos starten →